American Association for the Advancement of Science, Science Translational Medicine, 422(10), 2018
DOI: 10.1126/scitranslmed.aam7577
Full text: Unavailable
Intravenous infusion of oncolytic reovirus in patients leads to infection of brain tumors, infiltration by cytotoxic T cells, and up-regulation of PD-L1.